Literature DB >> 11217400

Clinical manifestations of New World hantaviruses.

D A Enria1, A M Briggiler, N Pini, S Levis.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11217400     DOI： 10.1007/978-3-642-56753-7_7

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  24 in total

Review 1.  The Syrian hamster model of hantavirus pulmonary syndrome.

Authors:  David Safronetz; Hideki Ebihara; Heinz Feldmann; Jay W Hooper
Journal:  Antiviral Res       Date:  2012-06-15       Impact factor: 5.970

Review 2.  Treatment of hantavirus pulmonary syndrome.

Authors:  Colleen B Jonsson; Jay Hooper; Gregory Mertz
Journal:  Antiviral Res       Date:  2007-11-21       Impact factor: 5.970

3.  Protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the Syrian hamster model of lethal Ebola virus infection.

Authors:  Yoshimi Tsuda; David Safronetz; Kyle Brown; Rachel LaCasse; Andrea Marzi; Hideki Ebihara; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

Review 4.  Global Diversity and Distribution of Hantaviruses and Their Hosts.

Authors:  Matthew T Milholland; Iván Castro-Arellano; Gerardo Suzán; Gabriel E Garcia-Peña; Thomas E Lee; Rodney E Rohde; A Alonso Aguirre; James N Mills
Journal:  Ecohealth       Date:  2018-04-30       Impact factor: 3.184

Review 5.  A global perspective on hantavirus ecology, epidemiology, and disease.

Authors:  Colleen B Jonsson; Luiz Tadeu Moraes Figueiredo; Olli Vapalahti
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

6.  Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.

Authors:  Kyle S Brown; David Safronetz; Andrea Marzi; Hideki Ebihara; Heinz Feldmann
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

7.  Neutrophil depletion suppresses pulmonary vascular hyperpermeability and occurrence of pulmonary edema caused by hantavirus infection in C.B-17 SCID mice.

Authors:  Takaaki Koma; Kumiko Yoshimatsu; Noriyo Nagata; Yuko Sato; Kenta Shimizu; Shumpei P Yasuda; Takako Amada; Sanae Nishio; Hideki Hasegawa; Jiro Arikawa
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

8.  Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus.

Authors:  David Safronetz; Nagendra R Hegde; Hideki Ebihara; Michael Denton; Gary P Kobinger; Stephen St Jeor; Heinz Feldmann; David C Johnson
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

9.  Hantavirus pulmonary syndrome in Canada: An overview of clinical features, diagnostics, epidemiology and prevention.

Authors:  M A Drebot; S Jones; A Grolla; D Safronetz; J E Strong; G Kobinger; R L Lindsay
Journal:  Can Commun Dis Rep       Date:  2015-06-04

10.  Behavioral, physiologic, and habitat influences on the dynamics of Puumala virus infection in bank voles (Clethrionomys glareolus).

Authors:  Sophie Escutenaire; Patrice Chalon; Florence De Jaegere; Lucie Karelle-Bui; Georges Mees; Bernard Brochier; Francine Rozenfeld; Paul-Pierre Pastoret
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.